Related Experiment Video
Updated: May 29, 2026

Examining the Role of Nasopharyngeal-associated Lymphoreticular Tissue (NALT) in Mouse Responses to Vaccines
Published on: August 1, 2012
Nasal-associated lymphoid tissue immunity and vaccine development
Satoru Kodama1, Masashi Suzuki
1Department of Otolaryngology, Oita University Faculty of Medicine, Hazama-cho, Yufu, Oita, Japan. satoruk@med.oita-u.ac.jp
Fms-like tyrosine kinase receptor-3 ligand (Flt3L) shows promise as a mucosal adjuvant for nasal vaccines. Nasal vaccination with Flt3L and P6 protein enhanced immune responses and improved clearance of nontypeable Haemophilus influenzae (NTHi).
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- Nasal vaccination offers a promising strategy for preventing upper respiratory infections.
- Developing effective nasal vaccines requires suitable adjuvants to enhance immune responses.
- Nontypeable Haemophilus influenzae (NTHi) is a significant pathogen causing respiratory infections.
Purpose of the Study:
- To evaluate the efficacy of fms-like tyrosine kinase receptor-3 ligand (Flt3L) as a mucosal adjuvant in a nasal vaccine formulation.
- To assess the induction of P6 protein-specific immune responses against NTHi following intranasal immunization.
- To determine the protective efficacy of Flt3L-adjuvanted nasal vaccination against NTHi challenge.
Main Methods:
- Mice were immunized intranasally with P6 protein of NTHi in combination with Flt3L.
- P6-specific immune responses, including immunoglobulin (Ig)A in nasal washes and IgG in serum, were measured.
- Dendritic cell populations in nasal-associated lymphoid tissue were analyzed.
- Mice were challenged with NTHi, and bacterial load in nasal washes was quantified.
Main Results:
- Nasal vaccination with P6 and Flt3L significantly increased the number of dendritic cells in nasal-associated lymphoid tissue.
- P6-specific IgA and serum IgG titers were significantly elevated post-immunization.
- A notable enhancement in NTHi clearance from the nasopharynx was observed in vaccinated mice.
Conclusions:
- Flt3L demonstrates potential as an effective mucosal adjuvant for nasal vaccine applications.
- Nasal vaccination incorporating P6 protein and Flt3L may represent a viable strategy for inducing protective immunity against NTHi.
- This approach warrants further investigation for the prevention of NTHi-related respiratory diseases.
Related Concept Videos
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Cells of the Adaptive Immune Response
Vaccinations
Functions of the Lymphatic and Immune System
The primary lymphoid organs, including the bone marrow and the thymus, serve as the maturation sites for lymphocytes. Secondary lymphoid organs, like the mucosa-associated lymphoid tissue, activate these lymphocytes and serve as...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Introduction to Lymphatic and Immune System
The immune responses can be categorized into two types: innate and adaptive. Innate immunity comprises nonspecific defenses we are born...

